Epigallocatechin-3-gallate suppressed breast oncogenesis via the miR-27a/Wnt/β-catenin pathway axis - Quiz - MDSpire

Epigallocatechin-3-gallate suppressed breast oncogenesis via the miR-27a/Wnt/β-catenin pathway axis

  • By

  • Shrila Banerjee

  • Abul Kalam Azad Mandal

  • June 11, 2026

  • 0 min

Share

Original Source(s)

Epigallocatechin-3-gallate suppressed breast oncogenesis via the miR-27a/Wnt/β-catenin pathway axis

  • by Shrila Banerjee, Abul Kalam Azad Mandal

  • June 11, 2026

Related Content

Correction: Converting an immunologically “cold” tumor: Exceptional response to cadonilimab plus chemotherapy in microsatellite-stable pancreatic cystadenocarcinoma

Editorial: Integrating nutrition in cancer therapy: approaches to improve patient outcomes and survival

Immune - cell death index in hepatocellular carcinoma: a multi-omics and machine learning study for prognosis and immunotherapy prediction